PBRM1 loss is a late event during the development of cholangiocarcinoma

Intrahepatic cholangiocarcinoma frequently shows loss of BAP1 and PBRM1 expression, and demonstrates specific clinicopathological and genetic characteristics with BAP1 loss

(2017) Kento Misumi et al.   HISTOPATHOLOGY

Loss of ARID1A Expression Presents a Novel Pathway of Carcinogenesis in Biliary Carcinomas

(2016) Motoko Sasaki et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Different prognostic roles of tumor suppressor geneBAP1in cancer: A systematic review with meta-analysis

(2016) Claudio Luchini et al.   GENES CHROMOSOMES & CANCER

Early-Stage Induction of SWI/SNF Mutations during Esophageal Squamous Cell Carcinogenesis

(2016) Hidetsugu Nakazato et al.   PLoS One

Decreased PBRM1 expression predicts unfavorable prognosis in patients with clear cell renal cell carcinoma

(2015) Soo Jeong Nam et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Prognostic role and implications of mutation status of tumor suppressor gene ARID1A in cancer: a systematic review and meta-analysis

(2015) Claudio Luchini et al.   Oncotarget

Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups

(2015) Michele Simbolo et al.   Oncotarget

The emerging roles of ARID1A in tumor suppression

(2014) Ren-Chin Wu et al.   CANCER BIOLOGY & THERAPY

Precursor neoplastic lesions of the biliary tract

(2014) Stefano Serra   JOURNAL OF CLINICAL PATHOLOGY

Pathogenesis and classification of intrahepatic cholangiocarcinoma: different characters of perihilar large duct type versus peripheral small duct type

(2014) Shinichi Aishima et al.   Journal of Hepato-Biliary-Pancreatic Sciences

Frequent mutations in chromatin-remodelling genes in pulmonary carcinoids

(2014) Lynnette Fernandez-Cuesta et al.   Nature Communications

Genomic analyses of gynaecologic carcinosarcomas reveal frequent mutations in chromatin remodelling genes

(2014) Siân Jones et al.   Nature Communications

Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation

(2013) Payal Kapur et al.   LANCET ONCOLOGY

Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas

(2013) Yuchen Jiao et al.   NATURE GENETICS

Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy

(2013) Cigall Kadoch et al.   NATURE GENETICS

Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma

(2012) Jeremy Schwartzentruber et al.   NATURE

BAP1 loss defines a new class of renal cell carcinoma

(2012) Samuel Peña-Llopis et al.   NATURE GENETICS

Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma

(2011) Ignacio Varela et al.   NATURE

Clinical diagnosis and staging of cholangiocarcinoma

(2011) Boris Blechacz et al.   Nature Reviews Gastroenterology & Hepatology

Molecular Mechanisms of Cholangiocarcinogenesis: Are Biliary Intraepithelial Neoplasia and Intraductal Papillary Neoplasms of the Bile Duct Precursors to Cholangiocarcinoma?

(2009) Kai Bickenbach et al.   Surgical Oncology Clinics of North America

Polybromo-1: The chromatin targeting subunit of the PBAF complex

(2008) Martin Thompson   BIOCHIMIE